Clinical Trial Update: Neoadjuvant Therapy With Toripalimab and JS004 Combined With Etoposide and Platinum Chemotherapy for Limited-stage Small Cell Lung Cancer : A Phase 2 Trial [Phase 2]

View source ↗

Summary

A Phase 2 neoadjuvant trial in limited-stage small cell lung cancer combines toripalimab and JS004 with etoposide and platinum chemotherapy, and is currently re…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Limited-stage Small Cell Lung Cancer

Drugs mentioned

• Etoposide (Etoposide)
• JS004 (JS004)
• Platinum-based chemotherapy (platinum-based chemotherapy)
• Toripalimab (Toripalimab)

Snippet

Sponsor: Shanghai Pulmonary Hospital, Shanghai, China | Conditions: Limited Stage Small Cell Lung Cancer | Phase 2 | Status: RECRUITING